Malusi Mtetwa: Tranexamic Acid – What Does the Evidence Tell Us?
Malusi Mtetwa, Academic Casual – Paramedicine at Charles Sturt University, Paramedic at South Australia Ambulance Service, shared a post on LinkedIn:
“ParaPodcast Podcast and CPD Activity: Tranexamic Acid (TXA) — What Does the Evidence Tell Us?
How did a low-cost medication change trauma care, and why do the findings differ across bleeding conditions?
In this episode of ParaPodcast: Paramedicine from Africa to the World, we are joined by Professor Ian Roberts to explore the evidence behind tranexamic acid (TXA), including the landmark CRASH and WOMAN trials, the HALT-IT trial, and the challenges of translating research into clinical practice.
We discuss the importance of early administration, the risks of extrapolating evidence between different bleeding conditions, trial design, and the patients who can be overlooked when research is translated into practice.”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 02:35Brian O Mahony: Promoting Physical Activity and Sport in Haemophilia Care
-
Oct 19, 2026, 02:34Rishabh Mishra: Does the Evidence Support Tranexamic Acid Formulations in Skincare?
-
Oct 18, 2026, 23:31Rana Al-Hrout: MAHA – More Than Schistocytes
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis
-
Oct 18, 2026, 17:04Emna Gouider Belhadjali: Don’t Miss GPAS 2026 on Bleeding Disorders
-
Oct 18, 2026, 16:53Mehran Ghasemzadeh: Microparticle-Associated Mitochondrial DNA in Stored Platelet Products
-
Oct 18, 2026, 16:38Edward Lee Carter: A 15-Minute Blood Test for Brain Hemorrhage?
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention